Algorithmic Machine Learning

FAR Biotech’s novel drug discovery technology blends existing empirical lab data with powerful machine learning algorithms to deliver a significantly faster discovery cycle at a fraction of the cost of typical drug development.

While most start-ups are typically single target ventures, FAR Biotech has developed a portfolio of diverse therapeutic targets and novel bio-active compounds that could be monetized on a stand-alone basis or as a pipeline

FAR Biotech’s technology platform consists of:

  • ~300 million compound library
  • ~1,000 quantum models related to ~200 human disease targets
  • Proprietary algorithms identifying unique molecular quantum patterns from empirical datasets that are associated with therapeutic biological activity
  • Ability to screen hundreds of thousands of compounds in matter of  days
    (rather than years in a lab setting)